Skip to main content
Clinical Trials/NCT01168661
NCT01168661
Completed
Not Applicable

Yoga, Mindfulness and Cognitive Psychotherapy as Treatment for Stress and Burnout

Karolinska Institutet1 site in 1 country90 target enrollmentAugust 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress, Psychological
Sponsor
Karolinska Institutet
Enrollment
90
Locations
1
Primary Endpoint
Reduced stress measured by qualitative questionnaires
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to investigate if treatment with yoga or mindfulness has a more profound and longstanding effect on stress and burnout than treatment with cognitive psychotherapy alone.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
April 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • On sick leave at least 50% at the beginning of the study.
  • Sick leave for a maximum of 1 year if on full-time sick leave at the beginning of the study or for a maximum of 3 years if on part-time sick leave at the beginning of the study.
  • Speak Swedish well enough to participate in the study interventions.
  • Body mass index (BMI) of between 18 and
  • Meet the diagnostic criteria for burnout syndrome from the Swedish National Board of Health and Welfare.

Exclusion Criteria

  • Medication, including all medication or topical skin preparations with cortisone in any form. Exceptions: Antidepressants, contraceptives, hormone replacement therapy for hypothyroidism if hormone levels were within the normal range, and hormone replacement therapy to treat menopausal symptoms. To receive an exception for medication, a participant had to take the same medication at the same dose at both blood tests.

Outcomes

Primary Outcomes

Reduced stress measured by qualitative questionnaires

Time Frame: 5 months after start of treatment

Level of stress will be measured by qualitiative questionnaries, including the Swedish Health-Related Quality of Life Survey (SWEQUAL).

Secondary Outcomes

  • Reduced cortisol secretion(5 months after start of treatment)

Study Sites (1)

Loading locations...

Similar Trials